Literature DB >> 17293184

Hospitalizations due to unstable angina pectoris in diastolic and systolic heart failure.

Ali Ahmed1, Michael R Zile, Michael W Rich, Jerome L Fleg, Kirkwood F Adams, Thomas E Love, James B Young, Wilbert S Aronow, Dalane W Kitzman, Mihai Gheorghiade, Louis J Dell'Italia.   

Abstract

Patients with diastolic heart failure (HF), i.e., clinical HF with normal or near normal left ventricular ejection fraction (LVEF), may develop unstable angina pectoris (UAP) due to epicardial atherosclerotic coronary artery disease and/or to subendocardial ischemia, even in the absence of coronary artery disease. However, the risk of UAP in ambulatory patients with diastolic HF has not been well studied. We examined incident hospitalizations due to UAP in 916 patients with diastolic HF (LVEF >45%) without significant valvular heart disease and 6,800 patients with systolic HF (LVEF <or=45%) in the Digitalis Investigation Group trial. During a 38-month median follow-up, 12% of patients (797 of 6,800) with systolic HF (incidence rate 435 per 10,000 person-years) and 15% of patients (138 of 916) with diastolic HF (incidence rate 536 per 10,000 person-years) were hospitalized for UAP (adjusted hazard ratio for diastolic HF 1.22, 95% confidence interval [CI] 1.02 to 1.47, p = 0.032). There was a graded increase in incident hospital admissions for UAP with increasing LVEF. Hospitalizations for UAP occurred in 11% (520 of 4,808, incidence rate 407 per 10,000 person-years), 14% (355 of 2,556, incidence rate 496 per 10,000 person-years), and 17% (60 of 352, incidence rate 613 per 10,000 person-years) of patients with HF, respectively, with LVEF values <35%, 35% to 55%, and >55%. Compared with patients with HF and an LVEF <35%, the adjusted hazard ratios for UAP hospitalization in those with LVEF values 35% to 55% and >55% were, respectively, 1.17 (95% CI 1.02 to 1.34, p = 0.028) and 1.57 (95% CI 1.20 to 2.07, p = 0.026). In conclusion, in ambulatory patients with chronic HF, a higher LVEF was associated with increased risk of hospitalizations due to UAP. As in patients with systolic HF, those with diastolic HF should be routinely evaluated for myocardial ischemia and managed accordingly.

Entities:  

Mesh:

Year:  2006        PMID: 17293184      PMCID: PMC2659173          DOI: 10.1016/j.amjcard.2006.08.056

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  The effect of digoxin on mortality and morbidity in patients with heart failure.

Authors: 
Journal:  N Engl J Med       Date:  1997-02-20       Impact factor: 91.245

2.  Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure.

Authors: 
Journal:  Control Clin Trials       Date:  1996-02

3.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

Review 4.  Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects.

Authors:  P Held
Journal:  Am J Cardiol       Date:  1993-03-25       Impact factor: 2.778

5.  Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy.

Authors:  J E Brush; R O Cannon; W H Schenke; R O Bonow; M B Leon; B J Maron; S E Epstein
Journal:  N Engl J Med       Date:  1988-11-17       Impact factor: 91.245

6.  Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

Authors: 
Journal:  N Engl J Med       Date:  1987-06-04       Impact factor: 91.245

7.  Microvascular angina pectoris in hypertensive patients with left ventricular hypertrophy and diagnostic value of exercise thallium-201 scintigraphy.

Authors:  M Iriarte; R Caso; N Murga; J M Faus; D Sagastagoitia; E Molinero; M López de Argumedo; J Boveda
Journal:  Am J Cardiol       Date:  1995-02-15       Impact factor: 2.778

8.  Congestive heart failure from left ventricular diastolic dysfunction in systemic hypertension.

Authors:  M Iriarte; N Murga; D Sagastagoitia; E Molinero; M Morillas; A Salcedo; P Estella; J Etxebeste
Journal:  Am J Cardiol       Date:  1993-02-01       Impact factor: 2.778

9.  Beta blockers and the primary prevention of nonfatal myocardial infarction in patients with high blood pressure.

Authors:  B M Psaty; T D Koepsell; E H Wagner; J P LoGerfo; T S Inui
Journal:  Am J Cardiol       Date:  1990-11-06       Impact factor: 2.778

10.  Capillary growth and geometry during long-term hypertension and myocardial hypertrophy in dogs.

Authors:  R J Tomanek; T J Wessel; D G Harrison
Journal:  Am J Physiol       Date:  1991-10
View more
  6 in total

Review 1.  Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions.

Authors:  Bharathi Upadhya; Dalane W Kitzman
Journal:  Am J Cardiovasc Drugs       Date:  2017-08       Impact factor: 3.571

2.  Incident coronary revascularization and subsequent mortality in chronic heart failure: a propensity-matched study.

Authors:  Grigorios Giamouzis; Syed Abbas Agha; O James Ekundayo; Inmaculada Aban; Thomas E Love; Casey Daniel; Javed Butler; Ali Ahmed
Journal:  Int J Cardiol       Date:  2008-12-11       Impact factor: 4.164

Review 3.  Integrating the myocardial matrix into heart failure recognition and management.

Authors:  Francis G Spinale; Michael R Zile
Journal:  Circ Res       Date:  2013-08-30       Impact factor: 17.367

4.  Digoxin and 30-day all-cause hospital admission in older patients with chronic diastolic heart failure.

Authors:  Taimoor Hashim; Shereen Elbaz; Kanan Patel; Charity J Morgan; Gregg C Fonarow; Jerome L Fleg; Gerald McGwin; Gary R Cutter; Richard M Allman; Sumanth D Prabhu; Michael R Zile; Robert C Bourge; Ali Ahmed
Journal:  Am J Med       Date:  2013-09-23       Impact factor: 4.965

Review 5.  Diastolic myofilament dysfunction in the failing human heart.

Authors:  Jolanda van der Velden
Journal:  Pflugers Arch       Date:  2011-04-13       Impact factor: 3.657

6.  Prognostic utility of cardiovascular magnetic resonance upright maximal treadmill exercise testing.

Authors:  Bunyapon Sukpraphrute; Brandon C Drafts; Pairoj Rerkpattanapipat; Timothy M Morgan; Paul M Kirkman; William O Ntim; Craig A Hamilton; Robert L Cockrum; W Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2015-11-25       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.